Fluoxetine Capsules

Fluoxetine capsules contain the active ingredient fluoxetine, a selective serotonin reuptake inhibitor that has received regulatory approval for the treatment of various psychiatric and mood-related conditions. This medication represents a second-generation antidepressant that was initially developed in the 1970s and has since become widely prescribed for multiple therapeutic indications.^[¹]

Fluoxetine may be considered for patients experiencing major depressive disorder, obsessive-compulsive disorder, panic disorder, bulimia nervosa, and premenstrual dysphoric disorder, among other conditions.^[²] The medication functions by potentially influencing neurotransmitter levels in the brain, particularly serotonin, which could contribute to improvements in mood, anxiety, and related symptoms.^[³]

Healthcare providers may recommend fluoxetine as part of a comprehensive treatment approach that could include psychotherapy, lifestyle modifications, and other supportive interventions.^[⁴] The decision to prescribe fluoxetine should always involve careful consideration of individual patient factors, medical history, and potential benefits versus risks.^[⁵]

Fluoxetine capsules are typically administered orally once daily, with or without food, as the presence of food does not significantly affect bioavailability.^[⁵³] For major depressive disorder in adults, the usual starting dose is 20 mg once daily in the morning, which may be adjusted based on clinical response and tolerability.^[⁵⁴] The maximum recommended daily dose for depression is typically 80 mg, though most patients respond to doses between 20-40 mg daily.^[⁵⁵]

Obsessive-compulsive disorder may require higher doses, often starting at 20 mg daily with potential increases to 60 mg daily based on therapeutic response.^[⁵⁶] Panic disorder treatment typically begins with 10 mg daily for one week, followed by an increase to 20 mg daily, with a maximum recommended dose of 60 mg daily.^[⁵⁷] Bulimia nervosa treatment generally involves 60 mg once daily, which may be the most effective dose for this indication.^[⁵⁸]

Pediatric dosing for children and adolescents typically starts at 10 mg daily, with potential increases to 20 mg daily after one week.^[⁵⁹] Elderly patients or those with hepatic impairment may require dose reductions or less frequent dosing.^[⁶⁰] Patients should be informed that therapeutic effects may not be apparent for 2-4 weeks after initiation.^[⁶¹] Discontinuation should be gradual to minimize potential withdrawal symptoms, though fluoxetine’s long half-life may reduce discontinuation syndrome risk.^[⁶²] Healthcare providers should monitor patients closely during dose adjustments and treatment initiation.^[⁶³]

Fluoxetine exerts its therapeutic effects through selective inhibition of the presynaptic serotonin reuptake transporter, which may result in increased availability of serotonin in synaptic spaces throughout the central nervous system.^[⁶] This mechanism involves blocking the reuptake transporter protein located in presynaptic terminals, potentially allowing serotonin to remain active for extended periods.^[⁷]

The drug demonstrates high selectivity for serotonin transporters while showing minimal affinity for norepinephrine or dopamine reuptake systems.^[⁸] Research suggests that fluoxetine may also interact with 5-HT2C receptors, which could contribute to increased norepinephrine and dopamine levels in certain brain regions.^[⁹] The medication undergoes extensive hepatic metabolism, primarily through the cytochrome P450 system, particularly CYP2D6, producing an active metabolite called norfluoxetine.^[¹⁰]

This active metabolite may contribute to the drug’s prolonged therapeutic effects and extended elimination half-life.^[¹¹] The pharmacokinetic properties of fluoxetine include excellent oral bioavailability of approximately 70-90% and extensive protein binding of about 94.5%.^[¹²] The drug readily crosses the blood-brain barrier, achieving a brain-to-plasma ratio of approximately 2.6:1.^[¹³]

Healthcare providers should not prescribe fluoxetine to patients with known hypersensitivity to fluoxetine or any components of the formulation.^[¹⁴] Concurrent use of monoamine oxidase inhibitors represents an absolute contraindication due to the significant risk of serotonin syndrome, a potentially life-threatening condition.^[¹⁵] Patients must discontinue MAOIs for at least 14 days before initiating fluoxetine therapy, and conversely, a washout period of at least 5 weeks may be necessary after stopping fluoxetine before starting an MAOI.^[¹⁶]

The combination of fluoxetine with thioridazine or pimozide is contraindicated due to the potential for dangerous QT interval prolongation and associated cardiac arrhythmias.^[¹⁷] Linezolid administration represents another contraindication when patients are receiving fluoxetine, as this combination could lead to serotonin syndrome.^[¹⁸] Patients with a history of severe allergic reactions to fluoxetine should not receive this medication.^[¹⁹]

Healthcare providers must exercise extreme caution in patients with certain cardiac conditions, particularly those with pre-existing QT prolongation or risk factors for ventricular arrhythmias.^[²⁰] Close-angle glaucoma may represent a relative contraindication, as fluoxetine could potentially precipitate acute glaucoma episodes.^[²¹]

Fluoxetine demonstrates significant potential for drug interactions due to its effects on hepatic cytochrome P450 enzymes, particularly CYP2D6 inhibition.^[²²] Concurrent use with other serotonergic medications, including other SSRIs, SNRIs, tricyclic antidepressants, tramadol, triptans, and St. John’s wort, may increase the risk of serotonin syndrome.^[²³] The combination of fluoxetine with warfarin requires careful monitoring due to increased bleeding risk through pharmacodynamic interactions affecting platelet function.^[²⁴]

NSAIDs and aspirin may potentiate bleeding risks when used concurrently with fluoxetine.^[²⁵] Fluoxetine can significantly increase plasma concentrations of tricyclic antidepressants, potentially requiring dose adjustments of these medications.^[²⁶] Antipsychotic medications may demonstrate increased serum levels when co-administered with fluoxetine, necessitating careful monitoring for enhanced side effects.^[²⁷] Benzodiazepines, particularly alprazolam and diazepam, may show increased plasma concentrations and prolonged effects when combined with fluoxetine.^[²⁸]

Certain anticonvulsants, including phenytoin and carbamazepine, may require therapeutic drug monitoring when used with fluoxetine.^[²⁹] Healthcare providers should carefully review all concurrent medications and consider potential interactions before prescribing fluoxetine.^[³⁰]

The most commonly reported adverse effects associated with fluoxetine therapy include gastrointestinal disturbances such as nausea, diarrhea, and decreased appetite.^[³¹] Central nervous system effects may include insomnia, headache, drowsiness, anxiety, nervousness, and tremor.^[³²] Sexual dysfunction represents a significant concern for many patients, potentially manifesting as decreased libido, delayed orgasm, or erectile dysfunction.^[³³] Dermatological reactions could include excessive sweating, rash, or increased photosensitivity.^[³⁴]

Some patients may experience activation symptoms, including agitation, restlessness, or in rare cases, precipitation of manic episodes.^[³⁵] Weight changes, both loss and gain, have been reported with fluoxetine use.^[³⁶] Cardiovascular effects, while uncommon, may include palpitations or changes in blood pressure.^[³⁷] Withdrawal symptoms could occur if fluoxetine is discontinued abruptly, though these tend to be less severe than with shorter half-life antidepressants.^[³⁸]

Rare but serious adverse effects may include serotonin syndrome, characterized by hyperthermia, altered mental status, and neuromuscular abnormalities.^[³⁹] Increased bleeding risk, particularly when combined with anticoagulants or antiplatelet medications, requires monitoring.^[⁴⁰] Healthcare providers should counsel patients about the potential for initial side effects that may diminish over time.^[⁴¹]

Fluoxetine use during pregnancy requires careful risk-benefit assessment, as the medication crosses the placental barrier and may affect fetal development.^[⁴²] Current evidence suggests that fluoxetine exposure during the first trimester may not significantly increase the risk of major congenital malformations.^[⁴³] However, some studies have indicated potential associations with cardiac septal defects, though the absolute risk remains low.^[⁴⁴] Third-trimester exposure may be associated with neonatal adaptation syndrome, characterized by respiratory distress, feeding difficulties, temperature instability, and irritability.^[⁴⁵]

The risk of persistent pulmonary hypertension of the newborn has been reported with SSRI use beyond 20 weeks of gestation, though this remains a rare occurrence.^[⁴⁶] Maternal use of fluoxetine in late pregnancy could potentially increase the risk of postpartum hemorrhage.^[⁴⁷] Healthcare providers must weigh these potential risks against the consequences of untreated depression during pregnancy.^[⁴⁸]

Breastfeeding mothers should be aware that fluoxetine and its active metabolite norfluoxetine are excreted into breast milk and may be detectable in nursing infants.^[⁴⁹] Some breastfed infants have experienced adverse effects including colic, irritability, and feeding difficulties^[⁵⁰] The long half-life of fluoxetine and its metabolite may result in accumulation in nursing infants^[⁵¹] Alternative antidepressants with lower breast milk excretion might be considered for breastfeeding mothers.^[⁵²]

Fluoxetine capsules should be stored at controlled room temperature between 20°C to 25°C (68°F to 77°F), with brief excursions permitted to 15°C to 30°C (59°F to 86°F).^[⁶⁴] The medication must be protected from light exposure and should be dispensed in a tight, light-resistant container.^[⁶⁵] Capsules should be kept in their original packaging until use to maintain product integrity and protect from environmental factors.^[⁶⁶]

Storage areas should be dry and away from excessive heat or moisture, such as bathrooms or areas near heating sources.^[⁶⁷] All medications should be stored out of reach and sight of children, using child-resistant closures when appropriate.^[⁶⁸] Healthcare facilities and pharmacies must ensure proper storage conditions are maintained throughout the supply chain.^[⁶⁹] Patients should be counseled on proper home storage to maintain drug stability and prevent accidental ingestion.^[⁷⁰]

Unused or expired fluoxetine should be disposed of through appropriate pharmaceutical waste disposal programs rather than household trash or sewage systems.^[⁷¹] Healthcare providers should instruct patients to check expiration dates and avoid using expired medication.^[⁷²] Temperature fluctuations during transport or storage could potentially affect drug stability and should be minimized.^[⁷³] Original packaging provides optimal protection against environmental factors that could compromise drug quality.^[⁷⁴]

1. Edinoff AN, Akuly HA, Hanna TA, Ochoa CO, Patti SJ, Ghaffar YA, Kaye AD, Viswanath O, Urits I, Boyer AG, Cornett EM, Kaye AM. Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review. Neurol Int. 2021 Aug 5;13(3):387-401. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395812/
2. National Institute of Mental Health. Selective Serotonin Reuptake Inhibitors (SSRIs). NIMH. https://www.nimh.nih.gov/health/topics/mental-health-medications/index.shtml
3. Mayo Clinic. Selective serotonin reuptake inhibitors (SSRIs). Mayo Clinic Health Information. https://www.mayoclinic.org/diseases-conditions/depression/in-depth/ssris/art-20044825
4. StatPearls Publishing. Fluoxetine. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK459223/
5. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder. APA Guidelines. https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf
6. Drug Bank Online. Fluoxetine: Uses, Interactions, Mechanism of Action. DrugBank Database. https://go.drugbank.com/drugs/DB00472
7. Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data. Hum Psychopharmacol. 2005 Apr;20(3):207-15. https://pubmed.ncbi.nlm.nih.gov/15744630/
8. Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review. Pharmaceuticals (Basel). 2021 Aug;13(3):38. https://www.mdpi.com/2035-8377/13/3/38
9. Fluoxetine: adverse effects and drug-drug interactions. J Toxicol Clin Toxicol. 1993;31(4):603-30. https://pubmed.ncbi.nlm.nih.gov/8254702/
10. Deodhar M, Rihani SBA, Darakjian L, Turgeon J, Michaud V. Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition. Pharmaceutics. 2021 Jan 23;13(2). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912198/
11. Changes in adverse events reported by patients during 6 months of fluoxetine therapy. J Clin Psychiatry. 1999 Jun;60(6):389-94. https://pubmed.ncbi.nlm.nih.gov/10401918/
12. The side effect profile and safety of fluoxetine. J Clin Psychiatry. 1985 Mar;46(3 Pt 2):59-67. https://pubmed.ncbi.nlm.nih.gov/3156126/
13. Chronic Intake of the Selective Serotonin Reuptake Inhibitor Fluoxetine Enhances Atherosclerosis. Arterioscler Thromb Vasc Biol. 2018 May;38(5):1007-1019. https://pubmed.ncbi.nlm.nih.gov/29567680/
14. MedlinePlus Drug Information. Fluoxetine. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a689006.html
15. Drugs.com. Fluoxetine Drug Uses, Dosage & Side Effects. https://www.drugs.com/fluoxetine.html
16. WebMD. Fluoxetine (Prozac, Sarafem, others): Uses, Side Effects, Interactions. https://www.webmd.com/drugs/2/drug-6997/prozac-oral/details
17. Drugs.com. Fluoxetine Interactions Checker. https://www.drugs.com/drug-interactions/fluoxetine.html
18. Mayo Clinic. Fluoxetine (oral route) Precautions. https://www.mayoclinic.org/drugs-supplements/fluoxetine-oral-route/precautions/drg-20063952
19. Medscape Reference. Prozac (fluoxetine) dosing, indications, interactions, adverse effects. https://reference.medscape.com/drug/prozac-fluoxetine-342955
20. Medical News Today. Fluoxetine oral capsule interactions: Other medications and more. https://www.medicalnewstoday.com/articles/drugs-fluoxetine-capsule-interactions
21. Fluoxetine Use During Pregnancy. Drugs.com Pregnancy Category Information. https://www.drugs.com/pregnancy/fluoxetine.html
22. NHS. Pregnancy, breastfeeding and fertility while taking fluoxetine. https://www.nhs.uk/medicines/fluoxetine-prozac/pregnancy-breastfeeding-and-fertility-while-taking-fluoxetine/
23. MotherToBaby. Fluoxetine (Prozac®). NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK582711/
24. UK Teratology Information Service. USE OF FLUOXETINE IN PREGNANCY. https://uktis.org/monographs/use-of-fluoxetine-in-pregnancy/
25. Drugs and Lactation Database (LactMed®). Fluoxetine. NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK501186/
26. Australian Prescriber. Antidepressants in pregnancy and breastfeeding. https://australianprescriber.tg.org.au/articles/antidepressants-in-pregnancy-and-breastfeeding.html
27. Drugs.com. Fluoxetine Dosage Guide + Max Dose, Adjustments. https://www.drugs.com/dosage/fluoxetine.html
28. Mayo Clinic. Fluoxetine (oral route) – Side effects & dosage. https://www.mayoclinic.org/drugs-supplements/fluoxetine-oral-route/description/drg-20063952
29. GoodRx. Prozac Dosage Guide: What’s the Recommended Prozac Dose? https://www.goodrx.com/prozac/dosage
30. Healthline. Prozac Dosage: Form, Strengths, How to Take, and More. https://www.healthline.com/health/drugs/prozac-dosage
31. NHS. How and when to take fluoxetine. https://www.nhs.uk/medicines/fluoxetine-prozac/how-and-when-to-take-fluoxetine/
32. MSF Medical Guidelines. FLUOXETINE oral. https://medicalguidelines.msf.org/en/viewport/EssDr/english/fluoxetine-oral-16683693.html
33. Stability of fluoxetine in stored plasma, aqueous, and methanolic solutions determined by HPLC with UV detection. J Chromatogr B Biomed Sci Appl. 2001 Mar 5;752(2):221-9. https://pubmed.ncbi.nlm.nih.gov/11338670/
34. The influence of temperature and time of storage on the stability of fluoxetine in biological material. Z Zagadnieñ Nauk S¹dowych. 2002;L:5-16. https://www.researchgate.net/publication/237476517_The_influence_of_temperature_and_time_of_storage_on_the_stability_of_fluoxetine_in_biological_material
35. Medicine Storage – An Uncontained Issue? Medsafe New Zealand. https://www.medsafe.govt.nz/profs/PUArticles/September2014MedicineStorage.htm
36. DailyMed. FLUOXETINE- fluoxetine hydrochloride liquid. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c856d72f-4a1a-4f75-ae54-c4ac83ddcfa1
37. Fluoxetine Solution: Package Insert / Prescribing Info. Drugs.com. https://www.drugs.com/pro/fluoxetine-solution.html
38. Fluoxetine: Package Insert / Prescribing Information. Drugs.com. https://www.drugs.com/pro/fluoxetine.html
39. Baystate Health. Medication Storage Temperature Guidelines. https://www.baystatehealth.org/articles/medication-storage-temperature-guidelines
40. NHS. Common questions about fluoxetine. https://www.nhs.uk/medicines/fluoxetine-prozac/common-questions-about-fluoxetine/
41. NHS. Side effects of fluoxetine. https://www.nhs.uk/medicines/fluoxetine-prozac/side-effects-of-fluoxetine/
42. Medical News Today. Fluoxetine: Side effects, dosage, uses, and more. https://www.medicalnewstoday.com/articles/322413
43. Drugs.com. Fluoxetine Side Effects: Common, Severe, Long Term. https://www.drugs.com/sfx/fluoxetine-side-effects.html
44. NHS. About fluoxetine. https://www.nhs.uk/medicines/fluoxetine-prozac/about-fluoxetine/
45. Drugs.com. Fluoxetine Patient Tips: 7 things you should know. https://www.drugs.com/tips/fluoxetine-patient-tips
46. YoungMinds. Fluoxetine | SSRI Uses, Warnings & Side Effects. https://www.youngminds.org.uk/young-person/medications/fluoxetine/
47. Patient.info. Fluoxetine – Olena, Oxactin, Prozac, Prozep; Depression medication. https://patient.info/medicine/fluoxetine-olena-prozac-prozep
48. On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor. Br J Pharmacol. 2001 Oct;134(4):827-31.
49. A common mechanism of action of the selective serotonin reuptake inhibitors citalopram and fluoxetine. Eur Neuropsychopharmacol. 2010 May;20(5):359-67.
50. ScienceDirect Topics. Fluoxetine – an overview. https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/fluoxetine
51. PubMed. Fluoxetine. https://pubmed.ncbi.nlm.nih.gov/29083803/
52. Wikipedia. Fluoxetine. https://en.wikipedia.org/wiki/Fluoxetine
53. Fluoxetine Practical Guide: Pharmacology, Indications. Psychopharmacology Institute. https://psychopharmacologyinstitute.com/publication/fluoxetine-practical-guide-pharmacology-indications-dosing-guidelines-and-adverse-effects-2822
54. United States Food and Drug Administration. Label for PROZAC (fluoxetine). https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s108lbl.pdf
55. Medicines in Pregnancy. Fluoxetine. https://www.medicinesinpregnancy.org/leaflets-a-z/fluoxetine/
56. MotherToBaby. Fluoxetine (Prozac®). https://mothertobaby.org/fact-sheets/fluoxetine-prozac-pregnancy/
57. Mayo Clinic. Antidepressants: Safe during pregnancy? https://www.mayoclinic.org/healthy-lifestyle/pregnancy-week-by-week/in-depth/antidepressants/art-20046420
58. The Fetal Safety of Fluoxetine: A Systematic Review. JOGC. https://www.jogc.com/article/S1701-2163(15)30965-8/pdf
59. StatPearls. Fluoxetine – StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK459223/
60. Mayo Clinic. Fluoxetine (oral route) – Side effects & dosage. https://www.mayoclinic.org/drugs-supplements/fluoxetine-oral-route/description/drg-20063952
61. NHS. Common questions about fluoxetine. https://www.nhs.uk/medicines/fluoxetine-prozac/common-questions-about-fluoxetine/
62. MedlinePlus. Fluoxetine: MedlinePlus Drug Information. https://medlineplus.gov/druginfo/meds/a689006.html
63. StatPearls. Fluoxetine – StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK459223/
64. NHS. About fluoxetine. https://www.nhs.uk/medicines/fluoxetine-prozac/about-fluoxetine/
65. Drugs.com. Fluoxetine: Package Insert / Prescribing Information. https://www.drugs.com/pro/fluoxetine.html
66. Drugs.com. Fluoxetine Patient Tips: 7 things you should know. https://www.drugs.com/tips/fluoxetine-patient-tips
67. YoungMinds. Fluoxetine | SSRI Uses, Warnings & Side Effects. https://www.youngminds.org.uk/young-person/medications/fluoxetine/
68. Drugs.com. Fluoxetine: Drug Uses, Dosage & Side Effects. https://www.drugs.com/fluoxetine.html
69. Patient.info. Fluoxetine – Olena, Oxactin, Prozac, Prozep. https://patient.info/medicine/fluoxetine-olena-prozac-prozep
70. WebMD. Fluoxetine (Prozac, Sarafem, others): Storage Information. https://www.webmd.com/drugs/2/drug-6997/prozac-oral/details

How long does it take for fluoxetine to work?
Most patients may begin to notice some improvement in symptoms after 1-2 weeks of treatment, though the full therapeutic benefit typically requires 4-6 weeks of consistent use.^[⁷⁵] Some individuals may require up to 8-12 weeks to experience maximum benefits.^[⁷⁶]

Can fluoxetine be taken with food?
Fluoxetine capsules may be taken with or without food, as meals do not significantly affect the medication’s absorption or effectiveness.^[⁷⁷] Taking the medication with food might help reduce gastrointestinal side effects in sensitive individuals.^[⁷⁸]

What should I do if I miss a dose?
If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose⁷⁹. Patients should not double the dose to make up for missed medication, as this could increase the risk of side effects.^[⁸⁰]

Can I drink alcohol while taking fluoxetine?
Alcohol consumption is generally not recommended while taking fluoxetine, as it may increase drowsiness and impair cognitive function.^[⁸¹] Healthcare providers typically advise limiting or avoiding alcohol during treatment.^[⁸²]

Will fluoxetine affect my ability to drive?
Fluoxetine may cause drowsiness, dizziness, or affect concentration in some patients, particularly during initial treatment.^[⁸³] Patients should assess their individual response before driving or operating machinery.^[⁸⁴]

Can I stop taking fluoxetine suddenly?
Abrupt discontinuation of fluoxetine is not recommended, as withdrawal symptoms may occur.^[⁸⁵] Healthcare providers typically recommend gradual dose reduction under medical supervision when discontinuing treatment.^[⁸⁶]

What are the most common side effects?
The most frequently reported side effects include nausea, headache, insomnia, diarrhea, dry mouth, and decreased appetite.^[⁸⁷] Most side effects are mild and may diminish as the body adjusts to the medication.^[⁸⁸]

How long will I need to take fluoxetine?
Treatment duration varies depending on individual circumstances and the condition being treated.^[⁸⁹] Healthcare providers typically recommend continued treatment for 6-12 months after symptoms improve to prevent relapse.^[⁹⁰]

Can fluoxetine cause weight changes?
Some patients may experience weight loss, particularly during initial treatment, while others might experience weight gain with long-term use.^[⁹¹] Individual responses vary significantly among patients.^[⁹²]

Is fluoxetine safe during pregnancy?
Pregnancy safety requires careful consideration of potential risks and benefits.^[⁹³] Healthcare providers must evaluate individual circumstances and may consider alternative treatments or close monitoring during pregnancy.[footnote]⁹⁴[footnote]

IMPORTANT DISCLAIMER: This product information is provided for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before starting, stopping, or modifying any medication regimen. The information presented herein does not constitute medical advice and should not be used as a substitute for consultation with a licensed healthcare professional. Individual patient responses to medications may vary significantly, and treatment decisions should always be made in consultation with appropriate medical supervision. This document does not imply endorsement, recommendation, or guarantee of safety or efficacy for any particular use. Healthcare providers should refer to current prescribing information and clinical guidelines when making treatment decisions.